The earnings call presented a mixed sentiment. While the company achieved significant gross margin expansion, record free cash flow, and international growth, it also faced substantial challenges with revenue decline, eye care supply chain issues, and retail order volatility. The overall sentiment leans towards negative due to the significant impact of these challenges on short-term performance and guidance.

Company Guidance

During the Q1 2026 earnings call, Prestige Consumer Healthcare, Inc. provided guidance highlighting several key financial metrics. The company reported Q1 sales of approximately $250 million, falling short of their forecasted range of $258 million to $260 million, mainly due to a prolonged production shutdown affecting the Clear Eyes brand. Despite this shortfall, the company achieved a gross margin expansion of 150 basis points to 56.2% and delivered an EPS of $0.95, up roughly 6% from the prior year, attributed to gross margin improvements and lower interest expenses. They recorded a quarterly record free cash flow of $78 million and maintained a leverage ratio of approximately 2.4x. Looking forward, Prestige anticipates FY 2026 revenues between $1.1 billion and $1.115 billion, with an adjusted EPS of $4.50 to $4.58. They expect significant improvements in Clear Eyes supply in the second half of FY 2026 and project a free cash flow of $245 million or more for the year.

Gross Margin Expansion

Gross margin expanded by 150 basis points to 56.2%, thanks to ongoing cost savings efforts.

Record Free Cash Flow

Quarterly free cash flow was a record $78 million, enabling capital deployment to enhance shareholder value.

Strong International Segment Growth

International segment revenues increased 7.1% versus the prior year, with broad-based growth by brand and geography.

Share Repurchase Activity

Repurchased over 400,000 shares in Q1, maintaining leverage ratio of approximately 2.4x.

EPS Growth

EPS increased approximately 6% versus the adjusted prior year, due to gross margin expansion and lower interest expense.

Prestige Consumer Healthcare (PBH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

PBH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2026 (Q2)	0.97 / -	1.09	―	―	―
Aug 07, 2025	2026 (Q1)	1.00 / 0.95	0.9	5.56% (+0.05)
May 08, 2025	2025 (Q4)	1.30 / 1.32	1.02	29.41% (+0.30)
Feb 06, 2025	2025 (Q3)	1.18 / 1.22	1.06	15.09% (+0.16)
Nov 07, 2024	2025 (Q2)	1.08 / 1.09	1.07	1.87% (+0.02)
Aug 08, 2024	2025 (Q1)	0.86 / 0.90	1.06	-15.09% (-0.16)
May 14, 2024	2024 (Q4)	1.14 / 1.02	1.07	-4.67% (-0.05)
Feb 08, 2024	2024 (Q3)	1.04 / 1.06	1.04	1.92% (+0.02)
Nov 02, 2023	2024 (Q2)	1.07 / 1.07	1.02	4.90% (+0.05)
Aug 03, 2023	2024 (Q1)	1.01 / 1.06	1.09	-2.75% (-0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

PBH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$75.16	$67.61	-10.05%
May 08, 2025	$81.41	$87.04	+6.92%
Feb 06, 2025	$76.10	$87.35	+14.78%
Nov 07, 2024	$77.64	$80.09	+3.16%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Prestige Consumer Healthcare (PBH) report earnings?

Prestige Consumer Healthcare (PBH) is schdueled to report earning on Oct 30, 2025, Before Open (Confirmed).

What is Prestige Consumer Healthcare (PBH) earnings time?

Prestige Consumer Healthcare (PBH) earnings time is at Oct 30, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is PBH EPS forecast?

PBH EPS forecast for the fiscal quarter 2026 (Q2) is 0.97.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing